PLASMA-CONCENTRATIONS OF ATRIAL NATRIURETIC PEPTIDE, ARGININE VASOPRESSIN AND HORMONES OF THE RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH END-STAGE RENAL-DISEASE

被引:12
|
作者
ELIAS, AN
VAZIRI, ND
PANDIAN, MR
KAUPKE, J
机构
来源
关键词
D O I
10.1177/039139888901200304
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:153 / 158
页数:6
相关论文
共 50 条
  • [41] The effect of renin–angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy
    Shigeru Tanaka
    Toshiharu Ninomiya
    Ritsuko Katafuchi
    Kosuke Masutani
    Masaharu Nagata
    Akihiro Tsuchimoto
    Hideki Hirakata
    Takanari Kitazono
    Kazuhiko Tsuruya
    Clinical and Experimental Nephrology, 2016, 20 : 689 - 698
  • [42] EFFECT OF HEMODIALYSIS ON PLASMA ADH LEVELS, PLASMA-RENIN ACTIVITY AND PLASMA-ALDOSTERONE LEVELS IN PATIENTS WITH END-STAGE RENAL-DISEASE
    IITAKE, K
    KIMURA, T
    MATSUI, K
    OTA, K
    SHOJI, M
    INOUE, M
    YOSHINAGA, K
    ACTA ENDOCRINOLOGICA, 1985, 110 (02): : 207 - 213
  • [43] EFFECT OF HEMODIALYSIS ON PLASMA-CONCENTRATIONS OF ATRIAL-NATRIURETIC-PEPTIDE IN ADULT PATIENTS WITH CHRONIC-RENAL-FAILURE
    ANDERSON, JV
    RAINE, AEG
    PROUDLER, A
    BLOOM, SR
    JOURNAL OF ENDOCRINOLOGY, 1986, 110 (02) : 193 - 196
  • [44] Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes
    Schievink, B.
    Kropelin, T.
    Mulder, S.
    Parving, H. -H.
    Remuzzi, G.
    Dwyer, J.
    Vemer, P.
    de Zeeuw, D.
    Heerspink, H. J. Lambers
    DIABETES OBESITY & METABOLISM, 2016, 18 (01): : 64 - 71
  • [45] Herbal medicine Oryeongsan (Wulingsan): Cardio-renal effects via modulation of renin-angiotensin system and atrial natriuretic peptide system
    Lee, Ho Sub
    Kim, Hye Yoom
    Ahn, You Mee
    Cho, Kyung Woo
    INTEGRATIVE MEDICINE RESEARCH, 2024, 13 (03)
  • [46] Plasma renin activities, angiotensin II concentrations, atrial natriuretic peptide concentrations and cardiopulmonary function values in dogs with severe heartworm disease
    Kitagawa, H
    Kitoh, K
    Inoue, H
    Ohba, Y
    Suzuki, F
    Sasaki, Y
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2000, 62 (04): : 453 - 455
  • [47] RENAL SODIUM HANDLING AND THE RENIN-ANGIOTENSIN SYSTEM (RAS) IN CHRONIC RENAL-FAILURE (CRF) DURING INFUSION OF ATRIAL NATRIURETIC PEPTIDE (ANP)
    BAYER, T
    MEYERLEHNERT, H
    GLANZER, K
    KRAMER, HJ
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 423 - 423
  • [48] ANGIOTENSIN-CONVERTING ENZYME IN PATIENTS WITH END-STAGE RENAL-DISEASE - INDICATOR OF BIOCOMPATIBILITY OF DIALYZER MEMBRANES
    KRAMER, B
    RESS, K
    ULSHOFER, T
    RISLER, T
    SEIPEL, L
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1986, 15 (10) : 456 - 459
  • [49] EFFECTS OF ANGIOTENSIN-II, ARGININE-VASOPRESSIN, ENDOTHELIN AND CATECHOLAMINES ON PLASMA ATRIAL-NATRIURETIC-PEPTIDE CONCENTRATIONS IN THE CONSCIOUS NEWBORN CALF
    AMADIEUFARMAKIS, M
    DAVICCO, MJ
    GIRY, J
    BARLET, JP
    JOURNAL OF DEVELOPMENTAL PHYSIOLOGY, 1991, 16 (01) : 51 - 56
  • [50] Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients
    Skoupy, S
    Födinger, M
    Veitl, M
    Perschl, A
    Puttinger, H
    Röhrer, C
    Schindler, K
    Vychytil, A
    Hörl, WH
    Sunder-Plassmann, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05): : 1331 - 1337